Cargando…
Reviewing Ligand-Based Rational Drug Design: The Search for an ATP Synthase Inhibitor
Following major advances in the field of medicinal chemistry, novel drugs can now be designed systematically, instead of relying on old trial and error approaches. Current drug design strategies can be classified as being either ligand- or structure-based depending on the design process. In this pap...
Autores principales: | Lee, Chia-Hsien, Huang, Hsuan-Cheng, Juan, Hsueh-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179167/ https://www.ncbi.nlm.nih.gov/pubmed/21954360 http://dx.doi.org/10.3390/ijms12085304 |
Ejemplares similares
-
Quantitative Proteomic Analysis of Human Lung Tumor Xenografts Treated with the Ectopic ATP Synthase Inhibitor Citreoviridin
por: Wu, Yi-Hsuan, et al.
Publicado: (2013) -
Ectopic ATP synthase stimulates the secretion of extracellular vesicles in cancer cells
por: Kao, Yi-Chun, et al.
Publicado: (2023) -
Spatial and temporal dynamics of ATP synthase from mitochondria toward the cell surface
por: Chang, Yi-Wen, et al.
Publicado: (2023) -
Quantitative phosphoproteomics reveals ectopic ATP synthase on mesenchymal stem cells to promote tumor progression via ERK/c-Fos pathway activation
por: Chang, Yi-Wen, et al.
Publicado: (2022) -
Structures of mycobacterial ATP synthase bound to inhibitors
por: Courbon, Gautier M., et al.
Publicado: (2022)